FEBS Lett by Tyurina, Yulia Y. et al.
Mitochondria targeting of non-peroxidizable
triphenylphosphonium conjugated oleic acid protects mouse
embryonic cells against apoptosis: Role of cardiolipin
remodeling
Yulia Y. Tyurina1,2,*, Muhammad A. Tungekar1,2, Mi-Yeon Jung1,2, Vladimir A. Tyurin1,2,
Joel S. Greenberger3, Detcho A. Stoyanovsky1,2, and Valerian E. Kagan1,2,*
1Center for Free Radical and Antioxidant Health, University of Pittsburgh, Pittsburgh, PA 15219,
USA
2Department of Environmental and Occupational Health, Graduate School of Public Health,
University of Pittsburgh, Pittsburgh, PA 15219, USA
3Department of Radiation Oncology, University of Pittsburgh, Pittsburgh, PA 15219, USA
Abstract
Peroxidation of cardiolipin in mitochondria is essential for the execution of apoptosis. We
suggested that integration of oleic acid into cardiolipin generates non-oxidizable cardiolipin
species hence protects cells against apoptosis. We synthesized mitochondria-targeted
triphenylphosphonium oleic acid ester. Using lipidomics analysis we found that pretreatment of
mouse embryonic cells with triphenylphosphonium oleic acid ester resulted in decreased contents
of polyunsaturated cardiolipins and elevation of its species containing oleic acid residues. This
caused suppression of apoptosis induced by actinomycin D. Triacsin C, an inhibitor of acyl-CoA
synthase, blocked integration of oleic acid into cardiolipin and restored cell sensitivity to
apoptosis.
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1. Introduction
Cardiolipin (CL) is a mitochondria-specific doubly charged anionic phospholipid with four
fatty acid residues [1]. In normal cells, it is exclusively localized to the inner mitochondrial
membrane (IMM) where it accounts for ~25% of all phospholipids [2]. CL is synthesized on
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the matrix side of the IMM [3,4] as a premature form that is deacylated by phospholipases A
to generate monolyso-CL [5,6,7]. The latter can be re-acylated by tafazzin, a mitochondrial
phospholipid trans-acylase [6,8] predominantly present in the IMM [9], to yield mature
species of CL [10]. In addition, mitochondria contain a coenzyme A-(CoA)-dependent
acyltransferase, mono-lyso-CL acyltransferase (MLCL AT), that acylates monolyso-CL to
CL [11]. Finally, endoplasmic reticulum (ER) acyl-CoA lyso-CL acyltransferase-1 (ALCAT
1), known to be upregulated by oxidative stress [12,13], can also catalyze synthesis of
polyunsaturated CL species [14].
In addition to CL’s multiple structural and signaling functions in normal cell physiology, it
is also an important player in apoptotic cell death pathways. Changes of the CL content and
oxidation status have been associated with the execution of extrinsic and intrinsic apoptosis
[15,16]. The early stage of intrinsic apoptosis is characterized by the formation of CL/
cytochrome c (cyt c) complexes in mitochondria that exhibit a potent peroxidase activity
towards polyunsaturated CL [17]. Polyunsaturated species of CL have been identified as a
preferred oxidation substrate of cyt c catalyzed reactions in vitro [18,19] and in vivo
[20,21,22,23]. Accumulation of CL oxidation products in mitochondria of apoptotic cells
has been found essential for the release of pro-apoptotic factors into the cytosol [17]. We
suggested that integration of mono-unsaturated oleic acid residues into mitochondrial CL –
via its remodeling pathways in mitochondria - will generate non-oxidizable CL species thus
protecting cells against apoptosis. We synthesized a poorly-peroxidizable
triphenylphosphonium (TPP) octadecaenoic acid (C18:1) ester (TPP-C18:1) and used it for
targeted delivery into mitochondria of mouse embryonic cells (MEC). Using liquid
chromatography/mass spectrometry (LC/MS) based lipidomics analysis we established that
pro-apoptotic stimulation with actinomycin D (AcD) was accompanied by selective
oxidative consumption of CL molecular species containing polyunsaturated octadecadienoic
(C18:2), eicosatetraenoic (C20:4), and docosahexaenoic (C22:6) acids. Pretreatment of MEC
with TPP-C18:1 resulted in: i) significant decrease of CL polyunsaturated molecular species
and simultaneous elevation of poorly-oxidizable CL molecular species containing C18:1 and
ii) suppression of AcD induced apoptosis. An inhibitor of long chain acyl-CoA synthase
(ACSL), triacsin C, blocked integration of C18:1 into CL molecules and restored MEC’s
sensitivity to AcD-induced apoptosis.
2. Methods
Synthesis of TPP-C18:1
3-[(Z)-octadec-9-enoyl]oxypropyl-triphenyl-phosphonium chloride: A suspension of C18:1
(1 mmol) and silver nitrate (2 mmol) was stirred at 25 °C for 2 hrs. (3-
bromopropyl)triphenylphosphonium bromide (1 mmol) was added and the reaction mixture
was further stirred at 25 °C for 12 hrs. Thereafter, the mixture was filtered and the filtrate
evaporated to dryness under reduced pressure. The remaining residue was re-dissolved in
50% methanol containing 1% NaHCO3 and 1% NaCl. The TPP ester was extracted with
ethyl acetate and the extract dried over Na2SO4. Evaporation of the organic solvent afforded
0.55 mmol of 3-[(Z)-octadec-9-enoyl]oxypropyl-triphenyl-phosphonium chloride (ESI-MS
analysis revealed a single peak with m/z = 585.4).
Cell culture
Mouse embryonic cells (MEC) were grown in Dulbecco’s Modified Eagle Medium
containing 15% fetal bovine serum, 25 mM HEPES, 0.05 mg/ml uridine, 0.05mM 2-
mercaptoethanol, 1x MEM (Invitrogen, Carlsbad, CA) and 100 U/ml penicillin/streptomycin
in a humidified atmosphere (5% CO2 plus 95% air). Cells were pretreated with TPP-C18:1
(1–50μM) at 37°C for 2 hrs and after that exposed to AcD (100 ng/ml) at 37°C for 16 hrs.
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To block ASCL cells were treated with triacsin C (10 μM) at 37°C for 30 min. Cell viability
was measured using AlamarBlue assay (Invitrogen, Carlsbad, CA). Apoptosis was evaluated
by phosphatidylserine (PS) externalization using Annexin V–FITC apoptosis detection kit
(Biovision, Mountain View, CA) and caspase 3/7 with a luminescence Caspase–Glo™ 3/7
assay kit (Promega, Madison, WI).
Analysis of CL
Lipids were extracted using the Folch procedure [24]. Lipid phosphorus was determined by
a micro-method [25]. LC/MS was performed using a Dionex Ultimate™ 3000 HPLC
coupled on-line to a linear ion trap mass spectrometer (LXQ Thermo-Fisher) as described
[21]. CL was separated by 2D-HPTLC [26] and fatty acids were analyzed by LC/MS after
hydrolysis of CL with porcine pancreatic phospholipase A2 (PLA2) as described [21].
Analysis of TPP-C18:1
Mitochondria were isolated from MEC treated with TPP-C18:1 (50 μM, for 2h at 37°C) as
described [27]. TPP-C18:1 was extracted from mitochondria by Folch procedure [24] and
LC/MS in positive mode was performed using a Dionex Ultimate™ 3000 HPLC coupled on-
line to a linear ion trap mass spectrometer (LXQ Thermo-Fisher). TPP-C18:1 and TPP were
separated on a normal phase column (Luna 3 μm Silica 100A, 150x2 mm, (Phenomenex,
Torrance CA)) with flow rate 0.2 mL/min using gradient solvents containing 5 mM
CH3COONH4 (A – n-hexane:2-propanol:water, 43:57:1 (v/v/v) and B - n-hexane:2-
propanol:water, 43:57:10 (v/v/v). At these conditions the retention times for TPP-C18:1 and
TPP were 27.9 and 50.6 min, respectively.
Statistics
The results are presented as mean ± S.E.M. values from at least three experiments, and
statistical analyses were performed by either paired/unpaired Student's t-test or one-way
ANOVA. The statistical significance of differences was set at p< 0.05
3. Results
AcD-induced apoptosis and oxidative consumption of CL in MEC
To avoid complications possibly associated with non-specific oxidative events commonly
accompanying the execution of apoptotic program triggered by redox-cycling agents (eg,
paraquat, tetracyclines antibiotics, quinones) as well as sources of oxidizing equivalents like
H2O2 we used a known non-oxidant inducer of mitochondria-dependent intrinsic cell death
pathway, AcD [28]. Accordingly, AcD induced apoptosis in MEC as evidenced by caspase
3/7 activation (Fig. 1Aa) and PS externalization (Fig. 1Ab). To assess the role of CL
peroxidation in AcD-induced apoptosis we employed LC/MS analysis of CL molecular
species. In a typical negative mode MS spectrum of CL from MECs, six clusters were
detectable (Fig. 1Ba). Thirty six molecular species of CLs contained oxidizable
polyunsaturated fatty acid residues [19]. We found a significant decrease in the amount of
polyunsaturated CLs in cells challenged with AcD (vs control cells) – in line with likely
peroxidative “consumption” of polyunsaturated molecular species of CL. The oxidation was
selective: significant decreases of the contents occurred only in four molecular species of CL
- with m/z 1448, m/z 1472, m/z 1494 and m/z 1496 - containing C18:2, C20:4, and C22:6 fatty
acid residues and corresponding to (C18:2)4, (C18:2)3(C20:4), (C18:2)2(C20:4)2 and
(C18:2)3(C22:6), respectively (Fig. 2Bb). Quantitative assessment of oxidized CL revealed
accumulation of oxidation products formed from these CL molecular species (Fig. 2Bc,d)
that were represented by species containing 1–4 oxygens in their fatty acid residues (Fig.
2Bc, inserts).
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Effect of TPP-C18:1 on AcD-induced apoptosis and CL oxidation in MEC
We reasoned that delivery of TPP-conjugated monounsaturated C18:1 into mitochondria
would favor its integration into CL through acyl-CoA-dependent remodeling pathways by
MLCL AT or ALCAT 1 [6,12,13]. Using an uncoupler might be diagnostic of potential-
driven accumulation of TPP-C18:1 in mitochondria. However, experiments with uncouplers
in cells are complicated by their cytotoxic effects. A recent study discovered another
intricacy in interactions of TPP-based penetrating ions with anions of fatty acids that can act
as mitochondria-targeted protonophorous uncouplers [29]. Therefore, we chose to employ
LC/MS to assess the content of TPP-C18:1 and its de-esterified product, TPP, in
mitochondria of cells exposed to TPP-C18:1. Direct LC/MS analysis demonstrated the
presence of TPP-C18:1 and its hydrolysis product, TPP in mitochondria of treated cells (Fig.
2a). Quantitative assessment revealed that the amount of TPP-C18:1 and TPP was 83.0 ± 5.2
and 41.0 ± 4.5 nmol/mg mitochondrial protein, respectively (Fig.2b). Given that
accumulation of TPP-conjugated non-modified and modified fatty acids such as dodecyl-
TPP, TPP-imidazole-substituted C18:0 and C18:1 in mitochondria has been demonstrated in
previous studies [27,29] - it is conceivable, although still hypothetic, that TPP-C18:1
employed in the present work also accumulated in mitochondria.
Interestingly, LC/MS analysis of lipids in TPP-C18:1 treated MEC revealed significant
decrease in the levels of exactly those CL species with polyunsaturated fatty acids (m/z
1448, m/z 1472, m/z 1494 and m/z 1496) that underwent oxidation in cells exposed to AcD.
At the same time, the content of C18:1-containing species of CL, particularly CL-(C18:1)4 (m/
z 1456) was markedly increased (Fig. 3Aab). In line with this, LC/MS analysis of fatty acids
after CL hydrolysis by PLA2 demonstrated the increase of C18:1 (Fig. 3Ac) and decrease of
C18:2, C20:4, C20:3, C22:6 and C22:5 fatty acid residues in CL molecules (Fig. 3Ad).
Assuming that CL peroxidation is essential for the execution of the mitochondrial segment
of apoptotic program, TPP-C18:1 should exert anti-apoptotic effect. Indeed, treatment with
TPP- C18:1 markedly increased resistance of MEC to AcD induced apoptosis as evidenced
by inhibition of PS externalization (Fig. 3Ba) and caspase 3/7 activity (Fig.3Bb). In contrast,
C18:1 without the TPP-moiety did not change cell viability and was not effective in
suppression of apoptosis in these cells (data not shown). Importantly, the AcD-induced
“oxidative consumption” of polyunsaturated CL molecular species was significantly less
pronounced in cells pre-treated with TPP-C18:1 (Fig. 4A). These results indicate that
selective CL remodeling leading to the accumulation of its non-peroxidizable species is
associated with the protection of cells against AcD-induced apoptosis.
Effect of triacsin C on AcD-induced apoptosis and CL oxidation in TPP-C18:1 treated MEC
To further verify that CL remodeling is responsible for anti-apoptotic effect of TPP-C18:1 ,
we utilized triacsin C – an inhibitor of ACSL, an enzyme that generates acyl-CoAs [30]. We
found that triacsin C treated cells exhibited high sensitivity to AcD-induced apoptosis and
abolished the anti-apoptotic effect of TPP-C18:1 (Fig.4B). Neither significant enrichment of
CL with C18:1 (Fig.4Cab) nor changes in CL oxidation (Fig. 4A) were detected in triacsin C
treated/TPP- C18:1 exposed cells compared to control. Thus, CL re-acylation pathway –
dependent on ACSL-driven formation of acyl-CoA - is the likely major contributor to the
anti-apoptotic effect of TPP-C18:1 in MEC.
4. Discussion
MEC are commonly used as a normal cell culture model for studies of cell death pathways
including apoptosis [31,32,33]. It has been demonstrated that MEC exhibit typical apoptotic
features such as DNA fragmentation, PS externalization, caspase 3/7 activation as well as
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cyt c release in response to different stimuli including AcD [17,19,34]. Because the goal of
this work was to develop protective strategies against apoptosis, we chose to employ a
model of normal, rather than tumor, cells for the current study.
Accumulation of CL oxidation products - predominantly CL-hydroperoxides – is a required
early stage of apoptosis essential for the release of pro-apoptotic factors - including cyt c –
from mitochondria into the cytosol [17]. This was uniformly characteristic of different pro-
apoptotic stimuli in cultured cells in vitro [18,19] and several types of exposures in vivo
such as total body irradiation [21,22], hyperoxia [20] and traumatic brain injury [23]. This
CL and its peroxidation may act as a mitochondrial switch regulating sensitivity of cells to
apoptosis [17] hence represent a new target for drug discovery. The peroxidation process is
catalyzed by an intermembrane space protein of mitochondria – cyt c - that forms a high
affinity peroxidase complex with polyunsaturated CLs [17]. Inhibitors of the peroxidase
activity effective in suppressing CL peroxidation have been shown to exert potent anti-
apoptotic effects [19,20,35]. Among those, mitochondria-targeted imidazole-substituted
fatty acids displayed a potent anti-apoptotic effect in vitro and in vivo resulting in significant
protection against acute radiation damage [27].
This work demonstrates, for the first time, that mitochondrial delivery of poorly peroxidizale
mono-unsaturated TPP-C18:1 resulted in remodeling of endogenous pool of CLs such that
CLs containing polyunsaturated fatty acid residues becomes less abundant while the content
of C18:1-containing species increased. This remodeling conferred increased resistance of
MEC to AcD induced apoptosis. Given that saturated fatty acid residues do not undergo
peroxidative modifications, they may represent an alternative group of compounds for CL
remodeling with potential anti-apoptotic consequences. However, it has been reported that
saturated fatty acids are poor substrates for CL reacylation reactions [13] and the rates of
their turnover in CLs are very low [36].
The diversity of CLs is defined by two major metabolic pathways - its biosynthesis and
remodeling. De novo synthesis via condensation of one molecule of phosphatidylglycerol
and one molecule of cytidine-5’-diphosphate-1,2-diacylglycerol catalyzed by CL synthase
(CLS1) takes place in mitochondria [3,4]. It is believed that de novo synthesis is responsible
for non-specific diversification of CL molecular species while acyl-specific remodeling
limits and fine-tunes the number of CL molecular species in different tissues [37]. At least
three enzymes are involved in remodeling of CL. Tafazzin, a mitochondrial phospholipid
transacylase - presents exclusively in the IMM [6,8,9] - transfers acyl residues,
predominantly linoleic acid, from PC and PE into monolyso-CL [38,39,40] independently of
CoA [41]. CoA-dependent remodeling of CLs can occur in both mitochondria and ER
[12,13]. It is catalyzed by MLCL AT and ALCAT 1 with high specificity towards poly- and
monounsaturated fatty acids [13]. Both enzymes utilize acyl-CoA as a substrate in the
reaction for acylation of mono-lyso-CL [11,13] and can be specifically down regulated
through inhibition of ACSL by triascin C [30]. In line with this, our results demonstrated
that triascin C effectively inhibited TPP-C18:1-driven remodeling of CL in MEC. Notably,
triascin C also restored sensitivity of TPP-C18:1-supplemented cells to AcD-induced
apoptosis suggesting that CoA-dependent remodeling is involved in modification of CL in
MEC exposed to TPP-C18:1.. This is further supported by our oxidative lipidomics
measurements which revealed that only four out of thirty six polyunsaturated molecular
species of CL were selectively oxidized in MEC during apoptosis triggered by AcD. By
metabolically manipulating these CL species and decreasing their susceptibility to
peroxidation we were be able to decrease the sensitivity of cells to apoptosis.
Our previous work established that by suppressing CLS1 by specific RNAi we were able to
cause CL-deficiency, decrease CL peroxidation thus increase resistance of HeLa cells
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challenged with AcD to apoptosis [28]. Here, we experimentally tested an alternative
approach based on manipulations of CL oxidizability using poorly-oxidizable C18:1. To
minimize C18:1 toxicity and deliver C18:1 into cells and mitochondria without damaging
them, we conjugated C18:1 with an organic cation TPP - commonly used for delivery
different payloads into mitochondria via “electrophoretic mechanism” based on negative
inside mitochondrial membrane potential [42,43,44]. TPP conjugated fatty acids can be
rapidly hydrolyzed intracellularly by esterases in mitochondria and ER [27]. Therefore,
unesterified C18:1 can be quickly activated by ACSL that present in the ER or mitochondria
[45,46] to C18:1-CoA and utilized for CL remodeling.
It is possible that enrichment of mitochondria with oleoyl-containing CL molecular species
may affect interactions of this essential anionic phospholipid with a number of
mitochondrial proteins such as cyt c oxidase [47,48], creatine kinase [49,50], ATP synthase
[51,52] mitochondrial ADP carrier [53] resulting in altered functional status. Our previous
work, however, demonstrated that depletion of 55% of endogenous CL in HeLa cells did not
affect their growth rate, mitochondria biomarker proteins and levels of ATP and
mitochondrial membrane potential [28]. Further, cyt c binding constant for tetra-oleoyl-CL
was similar to that of tetra-linoleoyl-CL [54].
In summary, we developed a new approach to regulate cell’s sensitivity to apoptosis via
manipulations of their CL’s oxidizability. While our findings on regulation of sensitivity to
apoptosis via manipulations of the CL’s oxidizability have been obtained using MEC as a
normal cell culture model, we suggest that this approach may be applicable to other cell
types as well. Indeed, oxygenation of CL molecular species during apoptosis of different
normal primary cell cultures, including lung epithelial cells, lung endothelial cells, rat
cortical neurons has been reported [18,20,21]. However, metabolic remodeling of CLs can
be utilized as an effective tool not only for suppressing (by non-oxidizable fatty acid
precursors) but also for enhancing (via highly oxidizable polyunsaturated fatty acid
precursors) apoptotic death pathway. In this way, this approach can be utilized for the
development of new therapeutic modalities to prevent excessive apoptosis or stimulate it in
cancer cells.
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IMM inner mitochondrial membrane
CoA coenzyme A-
MLCL AT mono-lyso-CL acyltransferase
ER endoplasmic reticulum
ALCAT 1acyl-CoA lyso-CL acyltransferase-1
ACSL long chain acyl-CoA synthase
PLA2 phospholipase A2
CLS1 CL synthase
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TPP-C18:1 triphenylphosphonium octadecaenoic acid ester
MEC mouse embryonic cells
LC-MS liquid chromatography-mass spectrometry
AcD actinomycin D
C20,4 eicosatetraenoic acid
C22,6 docosahexaenoic acid acids
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• Generation of non-oxidizable oleate-enriched cardiolipins via mitochondrial
targeting
• Desensitization to apoptosis via suppression of cardiolipjn oxidation
• Inhibition of long chain acyl-CoA synthase by triacsin C reinstates
polyunsaturation of cardiolipin and sensitivity to apoptosis.
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Figure 1. Apoptosis and CL oxidation induced by AcD in MEC
A - Apoptosis induced by AcD in MEC. (a) Caspase 3/7 activation and (b) PS
externalization in MEC exposed to AcD (100 ng/ml). Data are means ± S.E., n=10, *p<0.05
vs control. B - AcD-induced oxidation of CL in MEC. (a) Typical negative mode ESI-MS
spectrum of CL obtained from MEC, LC/MS quantitative assessment of oxidizable (b) and
oxidized (c) CL molecular species. CL oxidation products with 1–4 oxygens in each
oxidized CL molecular species were detected and shown on inserts. (d) Base peak
chromatogram of CL molecular species with m/z 1464. A higher intensity of the peak with
m/z 1464 corresponding to oxygenated CL molecular species ((C18:2)3(C18:2-OH), retention
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time 12.2 min) was detected in AcD treated MEC. Data are means ± S.E., n=7, *p<0.03 vs
control.
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Figure 2. LC/MS analysis of TPP-C18:1 and its hydrolysis product, TPP, in mitochondria of
MEC
A – LC/MS base peak profiles of TPP-C18:1 and TPP in mitochondria from MEC exposed to
TPP-C18:1. B - Quantitative assessment of TPP-C18:1 and TPP in mitochondria. Data are
means ± S.E. n=6.
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Figure 3. Modification of CL molecular species affects apoptosis induced by AcD in TPP-C18:1
treated MEC
A- Effect of TPP-C18:1 on the content of CL molecular species in MEC. Content of CL
molecular species in control (a) and TPP-C18:1 treated cells (b). Content of C18:1 (c) and
changes in CL fatty acid composition (d) in MEC treated with TPP-C18:1. The amounts of
CL molecular species with m/z 1448, m/z 1472, m/z 1494 and m/z 1496 in TPP-C18:1 treated
cells were dropped to 21.8 ± 3.3, 7.2 ± 2.0, 6.5 ± 2.3 and 5.4 ± 1.8 pmol/nmol of total CL
from 36.5 ± 3.6, 17.9 ± 4.3, 8.7 ± 1.6 and 8.6 ± 1.4 pmol/nmol of total CL in control cells,
respectively. Consequently, the amount of CL molecular species with m/z 1456 was
increased from 10.8 ± 2.7 to 58.6 ± 7.2 pmol/nmol of total CL. Data are means ± S.E., n =
3–10. B - Effect of TPP-C18:1 on AcD-induced phosphatidylserine externalization (a) and
caspase 3/7 activation (b) in MEC. Data are means ± S.E., n=8, *p<0.05 vs control.
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Figure 4. Effect of triascin C on apoptosis and CL oxidation induced by AcD in MEC treated
with TPP-C18:1
A -Effect of AcD, TPP-C18:1 and triacsin C on CL oxidation in MEC. Data are presented as
increase of oxidized CL molecular species. Data are means ± S.E., n=3–7, *p<0.05 vs
control. B - Effect of TPP-C18:1 and triacsin C on AcD-induced phopsphatidylserine
expernalization (a) and caspase 3/7 activation (b) in MEC. Data are means ± S.E., n=3–10,
*p<0.05 vs control. C- Content of CL molecular species in triacsin C treated (a) and triacsin
C treated TPP-C18:1 exposed cells (b). The amounts of CL molecular species with m/z 1448,
m/z 1472, m/z 1494 and m/z 1496 were estimated as 33.3 ± 1.9, 13.8 ± 2.0, 9.6 ± 1.8 and 6.5
± 1.6 pmol/nmol of total CL in triacsin C pre-treated and 37.6 ± 3.9, 11.0 ± 3.1, 6.6 ± 4.3
and 3.9 ± 3.1 pmol/nmol of total CL in triacsin pre-treated/TPP-C18:1 exposed cells,
respectively. Consequently, the amount of CL molecular species with m/z 1456 was 16.4 ±
3.4 to 24.7 ± 4.2 pmol/nmol of total CL. Data are means ± S.E., n=3–5.
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